These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 34080991)

  • 1. Emergency use authorisation of Covid-19 vaccines: An ethical conundrum.
    Vashishtha VM; Kumar P
    Indian J Med Ethics; 2021; VI(1):1-3. PubMed ID: 34080991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. People's Willingness to Vaccinate Against COVID-19 Despite Their Safety Concerns: Twitter Poll Analysis.
    Eibensteiner F; Ritschl V; Nawaz FA; Fazel SS; Tsagkaris C; Kulnik ST; Crutzen R; Klager E; Völkl-Kernstock S; Schaden E; Kletecka-Pulker M; Willschke H; Atanasov AG
    J Med Internet Res; 2021 Apr; 23(4):e28973. PubMed ID: 33872185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covid-19 vaccine trials and ethics: Protection delayed is protection denied.
    John TJ; Dharmapalan D
    Indian J Med Ethics; 2021; VI(1):1-5. PubMed ID: 34080997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should the SARS-CoV-2 vaccine be mandatory for nurses? An ethical debate.
    Osbourne RM; Clark SJ
    Br J Nurs; 2021 Jan; 30(2):116-121. PubMed ID: 33529104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covid-19 vaccines: The public must have confidence in the science.
    Srinivasan S
    Indian J Med Ethics; 2021; VI(1):1-6. PubMed ID: 34080989
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there a role for childhood vaccination against COVID-19?
    Eberhardt CS; Siegrist CA
    Pediatr Allergy Immunol; 2021 Jan; 32(1):9-16. PubMed ID: 33113210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The COVID-19 mRNA Vaccines and the Pandemic: Do They Represent the Beginning of the End or the End of the Beginning?
    Jhaveri R
    Clin Ther; 2021 Mar; 43(3):549-556. PubMed ID: 33579547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A COVID-19 vaccine-dare to dream.
    Phillis A
    Br J Community Nurs; 2020 Dec; 25(12):2-7. PubMed ID: 33275510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [COVID-19 vaccination for cancer patients: Medical and ethical need].
    Spano JP; Barre-Sinoussi F; Kieny MP; Marcelin AG; Blay JY
    Bull Cancer; 2021 Mar; 108(3):225-227. PubMed ID: 33674059
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccines: ethical framework concerning human challenge studies.
    Calina D; Hartung T; Docea AO; Spandidos DA; Egorov AM; Shtilman MI; Carvalho F; Tsatsakis A
    Daru; 2020 Dec; 28(2):807-812. PubMed ID: 32851596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Vaccines: Preparing for Vaccination in the Context of Clinical Oncology Care.
    Carr E
    Clin J Oncol Nurs; 2021 Feb; 25(1):76-84. PubMed ID: 33480870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 Vaccines: Where Are We Now?
    Flanagan KL; MacIntyre CR; McIntyre PB; Nelson MR
    J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3535-3543. PubMed ID: 34400116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials.
    Singh JA; Upshur REG
    Lancet Infect Dis; 2021 Apr; 21(4):e103-e109. PubMed ID: 33306980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad cross-national public support for accelerated COVID-19 vaccine trial designs.
    Broockman D; Kalla J; Guerrero A; Budolfson M; Eyal N; Jewell NP; Magalhaes M; Sekhon JS
    Vaccine; 2021 Jan; 39(2):309-316. PubMed ID: 33334616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations.
    Sultana J; Mazzaglia G; Luxi N; Cancellieri A; Capuano A; Ferrajolo C; de Waure C; Ferlazzo G; Trifirò G
    Expert Rev Vaccines; 2020 Oct; 19(10):919-936. PubMed ID: 32940090
    [No Abstract]   [Full Text] [Related]  

  • 17. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.
    Yin F; Wu Z; Xia X; Ji M; Wang Y; Hu Z
    J Med Internet Res; 2021 Jan; 23(1):e26089. PubMed ID: 33400682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 vaccines for low- and middle-income countries.
    Choi EM
    Trans R Soc Trop Med Hyg; 2021 May; 115(5):447-456. PubMed ID: 33733663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities.
    Wang EA; Zenilman J; Brinkley-Rubinstein L
    JAMA; 2020 Sep; 324(11):1031-1032. PubMed ID: 32808972
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 vaccine trials: The use of active controls and non-inferiority studies.
    Fleming TR; Krause PR; Nason M; Longini IM; Henao-Restrepo AM
    Clin Trials; 2021 Jun; 18(3):335-342. PubMed ID: 33535811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.